Published in

Journal of New Materials for Electrochemical Systems, 4(25), p. 234-239, 2022

DOI: 10.14447/jnmes.v25i4.a02

Links

Tools

Export citation

Search in Google Scholar

A DFT Study of Graphene as a Drug Carrier for Gemcitabine Anticancer Drug

Journal article published in 2022 by Abdulaziz A. M. Abahussain, S. Z. J. Zaidi, M. H. Nazir, M. Raza, S. Hassan ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.